Literature DB >> 121658

Increased plasma corticosteroid-binding globulin in insulin-dependent pubertal diabetics: relationships with other glycoproteins, growth hormone and prolactin.

A Angeli, U Ramenghi, S Del Bello, G Gaidano, F Cerutti, S Baratono.   

Abstract

A selected group of 13 juvenile-onset insulin-dependent diabetics in mid-late puberty (stages 3-4) and under comparable conditions of metabolic control was studied in order to evaluate the plasma levels of corticosteroid-binding globulin (CBG, transcortin: expressed as the binding capacity for cortisol) in relation to the levels of other glycoproteins and to growth hormone (GH) and prolactin (PRL) responsiveness to provocative tests (arginine infusion and TRH injection, respectively). Further evidence was provided that juvenile-onset diabetics show most frequently enhanced plasma CBG binding capacity; statistical significance with p-values less than 0.01 was attained in comparison to 25 age-matched controls. Among other variables examined, only hemoglobin A1c amd alpha 2-macroglobulin were significantly raised in the diabetic group (p less than 0.01 and less than 0.02, respectively). In our patients growth hormone response to arginine infusion was in the normal range, whereas PRL response to TRH was slightly but significantly supranormal in terms of maximum value and maximum increment above baseline value. No correlation was found between CBG binding capacity and other variables examined. We conclude that raised levels of CBG may occur as an additional alteration of the plasma glycoprotein pattern in juvenile-onset insulin-dependent diabetics. Specific regulatory factors conceivably subserve plasma concentrations of different glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 121658     DOI: 10.1007/bf02587650

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  30 in total

1.  Glucocorticoid regulation of plasma ketone body concentration in insulin devicient man.

Authors:  D S Schade; R P Eaton; J Standefer
Journal:  J Clin Endocrinol Metab       Date:  1977-06       Impact factor: 5.958

2.  Reversal by insulin treatment of abnormal growth hormone pattern in newly diagnosed diabetes mellitus.

Authors:  R J Corrall; W M Hunter; I W Campbell; A D Harrower; L J Duncan; B F Clarke
Journal:  Acta Endocrinol (Copenh)       Date:  1974-09

3.  A new method for the determination of the binding capacity of testosterone-estradiol-binding-globulin in human plasma.

Authors:  V P Shanbhag; R Södergård; H Carstensen; P A Albertsson
Journal:  J Steroid Biochem       Date:  1973-09       Impact factor: 4.292

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  Hemoglobin components in patients with diabetes mellitus.

Authors:  L A Trivelli; H M Ranney; H T Lai
Journal:  N Engl J Med       Date:  1971-02-18       Impact factor: 91.245

Review 6.  The binding of steroid hormones in human serum.

Authors:  W Rosner
Journal:  Prog Clin Biol Res       Date:  1976

7.  Diabetic retinopathy and prolactin.

Authors:  A Froland; C Hagen; E Lauritzen
Journal:  Lancet       Date:  1977-01-01       Impact factor: 79.321

8.  Rapid estimation (2 1/2 hours) of glycosylated haemoglobin for routine purposes.

Authors:  P A Kynoch; H Lehmann
Journal:  Lancet       Date:  1977-07-02       Impact factor: 79.321

9.  Cortisol binding capacity of plasma transcortin in diabetic subjects.

Authors:  P De Moor; W Heyns
Journal:  J Clin Endocrinol Metab       Date:  1967-05       Impact factor: 5.958

10.  Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus.

Authors:  K H Gabbay; K Hasty; J L Breslow; R C Ellison; H F Bunn; P M Gallop
Journal:  J Clin Endocrinol Metab       Date:  1977-05       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.